Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42594632)
Watch
English
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
scientific article published on March 2003
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
title
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
main subject
ocular hypertension
1 reference
based on heuristic
inferred from title
open-angle glaucoma
1 reference
based on heuristic
inferred from title
author
Luca Cimino
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
author name string
Stefano A Gandolfi
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
publication date
1 March 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
published in
Ophthalmology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
volume
110
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
page(s)
609-614
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
cites work
Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pharmacology of bimatoprost (Lumigan).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Latanoprost for uncontrolled glaucoma in a compassionate case protocol
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901891-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0161-6420(02)01891-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
PubMed publication ID
12623831
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12623831
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12623831%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
